SlideShare a Scribd company logo
Antiarrhythmic DrugsAntiarrhythmic Drugs
OrOr
Doing Drugs for Your HeartbeatDoing Drugs for Your Heartbeat
BackgroundBackground
Recall: to function efficiently, heart needs to contractRecall: to function efficiently, heart needs to contract
sequentially (atria, then ventricles) and in synchronicitysequentially (atria, then ventricles) and in synchronicity
Relaxation must occur between contractions (not true forRelaxation must occur between contractions (not true for
other types of muscle [exhibit tetanyother types of muscle [exhibit tetany  contract and holdcontract and hold
contraction for certain length of time])contraction for certain length of time])
Coordination of heartbeat is a result of a complex,Coordination of heartbeat is a result of a complex,
coordinated sequence of changes in membranecoordinated sequence of changes in membrane
potentials and electrical discharges in various heartpotentials and electrical discharges in various heart
tissuestissues
ArrhythmiaArrhythmia
Heart condition where disturbances inHeart condition where disturbances in

Pacemaker impulse formationPacemaker impulse formation

Contraction impulse conductionContraction impulse conduction

Combination of the twoCombination of the two
Results in rate and/or timing of contraction ofResults in rate and/or timing of contraction of
heart muscle that is insufficient to maintainheart muscle that is insufficient to maintain
normal cardiac output (CO)normal cardiac output (CO)
To understand how antiarrhythmic drugs work,To understand how antiarrhythmic drugs work,
need to understand electrophysiology ofneed to understand electrophysiology of
normal contraction of heartnormal contraction of heart
Normal heartbeat and atrial arrhythmiaNormal heartbeat and atrial arrhythmia
Normal rhythm Atrial arrhythmia
AV septum
Ventricular ArrhythmiaVentricular Arrhythmia
Ventricular arrhythmias areVentricular arrhythmias are
common in most people and arecommon in most people and are
usually not a problem but…usually not a problem but…
VA’s are most common cause ofVA’s are most common cause of
sudden deathsudden death
Majority of sudden death occurs inMajority of sudden death occurs in
people with neither a previouslypeople with neither a previously
known heart disease nor history ofknown heart disease nor history of
VA’sVA’s
Medications which decreaseMedications which decrease
incidence of VA’s do not decreaseincidence of VA’s do not decrease
(and may increase) the risk of(and may increase) the risk of
sudden deathsudden death treatment may betreatment may be
worse then the disease!worse then the disease!
Electrophysiology - resting potentialElectrophysiology - resting potential
A transmembrane electrical gradient (potential) isA transmembrane electrical gradient (potential) is
maintained, with the interior of the cell negative withmaintained, with the interior of the cell negative with
respect to outside the cellrespect to outside the cell
Caused by unequal distribution of ions inside vs. outsideCaused by unequal distribution of ions inside vs. outside
cellcell

NaNa++
higher outside than inside cellhigher outside than inside cell

CaCa++
much higher “ “ “ “much higher “ “ “ “

KK++
higher inside cell than outsidehigher inside cell than outside
Maintenance by ion selective channels, active pumpsMaintenance by ion selective channels, active pumps
and exchangersand exchangers
ECG (EKG) showing wave
segments
Contraction of
atria
Contraction of
ventricles
Repolarization of
ventricles
Cardiac Action PotentialCardiac Action Potential
Divided into five phases (0,1,2,3,4)Divided into five phases (0,1,2,3,4)

Phase 4Phase 4 - resting phase (resting membrane potential)- resting phase (resting membrane potential)
Phase cardiac cells remain in until stimulatedPhase cardiac cells remain in until stimulated
Associated with diastole portion of heart cycleAssociated with diastole portion of heart cycle
Addition of current into cardiac muscle (stimulation)Addition of current into cardiac muscle (stimulation)
causescauses

Phase 0Phase 0 – opening of fast Na channels and rapid depolarization– opening of fast Na channels and rapid depolarization
Drives NaDrives Na++
into cell (inward current), changing membrane potentialinto cell (inward current), changing membrane potential
Transient outward current due to movement of ClTransient outward current due to movement of Cl--
and Kand K++

Phase 1Phase 1 – initial rapid repolarization– initial rapid repolarization
Closure of the fast NaClosure of the fast Na++
channelschannels
Phase 0 and 1 together correspond to the R and S waves of thePhase 0 and 1 together correspond to the R and S waves of the
ECGECG
Cardiac Na+ channelsCardiac Na+ channels
Cardiac Action Potential (con’t)Cardiac Action Potential (con’t)
Phase 2Phase 2 - plateau phase- plateau phase

sustained by the balance between the inward movement of Casustained by the balance between the inward movement of Ca++
andand
outward movement of Koutward movement of K ++

Has a long duration compared to other nerve and muscle tissueHas a long duration compared to other nerve and muscle tissue

Normally blocks any premature stimulator signals (other muscle tissueNormally blocks any premature stimulator signals (other muscle tissue
can accept additional stimulation and increase contractility in acan accept additional stimulation and increase contractility in a
summation effect)summation effect)

Corresponds to ST segment of the ECG.Corresponds to ST segment of the ECG.
Phase 3Phase 3 – repolarization– repolarization

KK++
channels remain open,channels remain open,

Allows KAllows K++
to build up outside the cell, causing the cell to repolarizeto build up outside the cell, causing the cell to repolarize

KK ++
channels finally close when membrane potential reaches certain levelchannels finally close when membrane potential reaches certain level

Corresponds to T wave on the ECGCorresponds to T wave on the ECG
Differences between nonpacemaker andDifferences between nonpacemaker and
pacemaker cell action potentialspacemaker cell action potentials
PCs - Slow, continuous depolarization during restPCs - Slow, continuous depolarization during rest
Continuously moves potential towards threshold for aContinuously moves potential towards threshold for a
new action potential (called a phase 4 depolarization)new action potential (called a phase 4 depolarization)
Mechanisms of Cardiac ArrhythmiasMechanisms of Cardiac Arrhythmias
Result from disorders of impulseResult from disorders of impulse
formation, conduction, or bothformation, conduction, or both
Causes of arrhythmiasCauses of arrhythmias

Cardiac ischemiaCardiac ischemia

Excessive discharge or sensitivity toExcessive discharge or sensitivity to
autonomic transmittersautonomic transmitters

Exposure to toxic substancesExposure to toxic substances

Unknown etiologyUnknown etiology
Disorders of impulse formationDisorders of impulse formation
No signal from the pacemaker siteNo signal from the pacemaker site
Development of an ectopic pacemakerDevelopment of an ectopic pacemaker

May arise from conduction cells (most are capable ofMay arise from conduction cells (most are capable of
spontaneous activity)spontaneous activity)

Usually under control of SA nodeUsually under control of SA node  if it slows down too muchif it slows down too much
conduction cells could become dominantconduction cells could become dominant

Often a result of other injury (ischemia, hypoxia)Often a result of other injury (ischemia, hypoxia)
Development of oscillatory afterdepolariztionsDevelopment of oscillatory afterdepolariztions

Can initiate spontaneous activity in nonpacemaker tissueCan initiate spontaneous activity in nonpacemaker tissue

May be result of drugs (digitalis, norepinephrine) used to treatMay be result of drugs (digitalis, norepinephrine) used to treat
other cardiopathologiesother cardiopathologies
AfterdepolarizationsAfterdepolarizations
Disorders of impulse conductionDisorders of impulse conduction
May result inMay result in

Bradycardia (if have AV block)Bradycardia (if have AV block)

Tachycardia (if reentrant circuit occurs)Tachycardia (if reentrant circuit occurs)
Reentrant
circuit
Antiarrhythmic drugsAntiarrhythmic drugs
Biggest problem – antiarrhythmics canBiggest problem – antiarrhythmics can
cause arrhythmia!cause arrhythmia!

Example: Treatment of a non-life threateningExample: Treatment of a non-life threatening
tachycardia may cause fatal ventriculartachycardia may cause fatal ventricular
arrhythmiaarrhythmia

Must be vigilant in determining dosing, bloodMust be vigilant in determining dosing, blood
levels, and in follow-up when prescribinglevels, and in follow-up when prescribing
antiarrhythmicsantiarrhythmics
Therapeutic overviewTherapeutic overview
NaNa++
channel blockadechannel blockade
ββ-adrenergic receptor blockade-adrenergic receptor blockade
Prolong repolarizationProlong repolarization
CaCa2+2+
channel blockadechannel blockade
AdenosineAdenosine
Digitalis glycosidesDigitalis glycosides
Classification of antiarrhythmicsClassification of antiarrhythmics
(based on mechanisms of action)(based on mechanisms of action)
Class I – blocker’s of fast NaClass I – blocker’s of fast Na++
channelschannels

Subclass IASubclass IA
Cause moderate Phase 0 depressionCause moderate Phase 0 depression
Prolong repolarizationProlong repolarization
Increased duration of action potentialIncreased duration of action potential
IncludesIncludes

QuinidineQuinidine – 1– 1stst
antiarrhythmic used, treat both atrial andantiarrhythmic used, treat both atrial and
ventricular arrhythmias, increases refractory periodventricular arrhythmias, increases refractory period

ProcainamideProcainamide - increases refractory period but side- increases refractory period but side
effectseffects

DisopyramideDisopyramide – extended duration of action, used only– extended duration of action, used only
for treating ventricular arrthymiasfor treating ventricular arrthymias
Classification of antiarrhythmicsClassification of antiarrhythmics
(based on mechanisms of action)(based on mechanisms of action)

Subclass IBSubclass IB
Weak Phase 0 depressionWeak Phase 0 depression
Shortened depolarizationShortened depolarization
Decreased action potential durationDecreased action potential duration
IncludesIncludes

LidocaneLidocane (also acts as local anesthetic) – blocks Na+(also acts as local anesthetic) – blocks Na+
channels mostly in ventricular cells, also good forchannels mostly in ventricular cells, also good for
digitalis-associated arrhythmiasdigitalis-associated arrhythmias

MexiletineMexiletine - oral lidocaine derivative, similar activity- oral lidocaine derivative, similar activity

PhenytoinPhenytoin – anticonvulsant that also works as– anticonvulsant that also works as
antiarrhythmic similar to lidocaneantiarrhythmic similar to lidocane
Classification of antiarrhythmicsClassification of antiarrhythmics
(based on mechanisms of action)(based on mechanisms of action)

Subclass ICSubclass IC
Strong Phase 0 depressionStrong Phase 0 depression
No effect of depolarizationNo effect of depolarization
No effect on action potential durationNo effect on action potential duration
IncludesIncludes

FlecainideFlecainide (initially developed as a local anesthetic)(initially developed as a local anesthetic)
Slows conduction in all parts of heart,Slows conduction in all parts of heart,
Also inhibits abnormal automaticityAlso inhibits abnormal automaticity

PropafenonePropafenone
Also slows conductionAlso slows conduction
WeakWeak ββ – blocker– blocker
Also some CaAlso some Ca2+2+
channel blockadechannel blockade
Classification of antiarrhythmicsClassification of antiarrhythmics
(based on mechanisms of action)(based on mechanisms of action)
Class II –Class II – ββ–adrenergic blockers–adrenergic blockers

Based on two major actionsBased on two major actions
1) blockade of myocardial1) blockade of myocardial ββ–adrenergic receptors–adrenergic receptors
2) Direct membrane-stabilizing effects related to Na2) Direct membrane-stabilizing effects related to Na++
channel blockadechannel blockade

IncludesIncludes
PropranololPropranolol

causes both myocardialcauses both myocardial ββ–adrenergic blockade and membrane-–adrenergic blockade and membrane-
stabilizing effectsstabilizing effects

Slows SA node and ectopic pacemakingSlows SA node and ectopic pacemaking

Can block arrhythmias induced by exercise or apprehensionCan block arrhythmias induced by exercise or apprehension

OtherOther ββ–adrenergic blockers have similar therapeutic effect–adrenergic blockers have similar therapeutic effect
MetoprololMetoprolol
NadololNadolol
AtenololAtenolol
AcebutololAcebutolol
PindololPindolol
StalolStalol
TimololTimolol
EsmololEsmolol
Classification of antiarrhythmicsClassification of antiarrhythmics
(based on mechanisms of action)(based on mechanisms of action)
Class III – KClass III – K++
channel blockerschannel blockers

Developed because some patients negativelyDeveloped because some patients negatively
sensitive to Na channel blockers (they died!)sensitive to Na channel blockers (they died!)

Cause delay in repolarization and prolongedCause delay in repolarization and prolonged
refractory periodrefractory period

IncludesIncludes
AmiodaroneAmiodarone – prolongs action potential by delaying K– prolongs action potential by delaying K++
effluxefflux
but many other effects characteristic of other classesbut many other effects characteristic of other classes
IbutilideIbutilide – slows inward movement of Na– slows inward movement of Na++
in addition toin addition to
delaying Kdelaying K ++
influx.influx.
BretyliumBretylium – first developed to treat hypertension but found to– first developed to treat hypertension but found to
also suppress ventricular fibrillation associated withalso suppress ventricular fibrillation associated with
myocardial infarctionmyocardial infarction
Dofetilide - prolongs action potential by delaying KDofetilide - prolongs action potential by delaying K++
efflux withefflux with
no other effectsno other effects
Classification of antiarrhythmicsClassification of antiarrhythmics
(based on mechanisms of action)(based on mechanisms of action)
Class IV – CaClass IV – Ca2+2+
channel blockerschannel blockers

slow rate of AV-conduction in patients withslow rate of AV-conduction in patients with
atrial fibrillationatrial fibrillation

IncludesIncludes
Verapamil – blocks NaVerapamil – blocks Na++
channels in addition to Cachannels in addition to Ca2+;2+;
also slows SA node in tachycardiaalso slows SA node in tachycardia
DiltiazemDiltiazem
PacemakersPacemakers
Surgical implantation of electrical leads attached to aSurgical implantation of electrical leads attached to a
pulse generatorpulse generator
Over 175,000 implanted per yearOver 175,000 implanted per year
1)1) Leads are inserted via subclavicle vein and advanced to theLeads are inserted via subclavicle vein and advanced to the
chambers on the vena cava (right) side of the heartchambers on the vena cava (right) side of the heart
2)2) Two leads used, one for right atrium, other for right ventricleTwo leads used, one for right atrium, other for right ventricle
3)3) Pulse generator containing microcircuitry and battery arePulse generator containing microcircuitry and battery are
attached to leads and placed into a “pocket” under the skinattached to leads and placed into a “pocket” under the skin
near the claviclenear the clavicle
4)4) Pulse generator sends signal down leads in programmedPulse generator sends signal down leads in programmed
sequence to contract atria, then ventriclessequence to contract atria, then ventricles
Pulse generator can sense electrical activity generatedPulse generator can sense electrical activity generated
by the heart and only deliver electrical impulses whenby the heart and only deliver electrical impulses when
needed.needed.
Pacemakers can only speed up a heart experiencingPacemakers can only speed up a heart experiencing
bradycardia, they cannot alter a condition ofbradycardia, they cannot alter a condition of
tachycardiatachycardia
Implantation of PacemakerImplantation of Pacemaker

More Related Content

What's hot

Nitrates
NitratesNitrates
Antiarrhythmics
AntiarrhythmicsAntiarrhythmics
Antiarrhythmics
Dr. Marya Ahsan
 
Heart- Physiology and Electrophysiology
Heart- Physiology and ElectrophysiologyHeart- Physiology and Electrophysiology
Heart- Physiology and Electrophysiology
Surya Prajapat
 
Class antiarrhythmic drugs
Class antiarrhythmic drugsClass antiarrhythmic drugs
Class antiarrhythmic drugsRaghu Prasada
 
arrhythmia management
arrhythmia management arrhythmia management
arrhythmia management
Dr.Abhishek Reddy K
 
Antiarrhythmic drugs
Antiarrhythmic drugsAntiarrhythmic drugs
Antiarrhythmic drugs
Suresh Kumar Ghritlahare
 
Drugs acting on Renin Angiotensin Aldosterone system
Drugs acting on Renin Angiotensin Aldosterone system Drugs acting on Renin Angiotensin Aldosterone system
Drugs acting on Renin Angiotensin Aldosterone system
Dr Htet
 
Antiarrhythmic agent
Antiarrhythmic agentAntiarrhythmic agent
Antiarrhythmic agent
Subramani Parasuraman
 
Antiarrhythmic Drugs
Antiarrhythmic DrugsAntiarrhythmic Drugs
Antiarrhythmic Drugs
Dr.Sayeedur Rumi
 
Cardiac electrophysiology
Cardiac electrophysiologyCardiac electrophysiology
Cardiac electrophysiology
Kirtan Bhatt
 
14.antianginal drugs
14.antianginal drugs14.antianginal drugs
14.antianginal drugs
Dr.Manish Kumar
 
Arrhythmia & Antiarrhythmic Drugs
Arrhythmia & Antiarrhythmic DrugsArrhythmia & Antiarrhythmic Drugs
Arrhythmia & Antiarrhythmic Drugs
Dr. Ravi Sankar
 
Antiarrhythmic drugs bds
Antiarrhythmic drugs bdsAntiarrhythmic drugs bds
Antiarrhythmic drugs bds
Naser Tadvi
 
Pharmacology antiarrhythmias
Pharmacology   antiarrhythmiasPharmacology   antiarrhythmias
Pharmacology antiarrhythmiasMBBS IMS MSU
 
Diuretics
DiureticsDiuretics
Diuretics
Reza Heidari
 
Antiarrhythmic agent.pptx
Antiarrhythmic agent.pptxAntiarrhythmic agent.pptx
Antiarrhythmic agent.pptx
Subramani Parasuraman
 
Antiarrythmic drugs
Antiarrythmic drugs  Antiarrythmic drugs
Antiarrythmic drugs
munnam37
 
1.1 introduction of haemodynamics and electrophysiology of heart
1.1 introduction of haemodynamics and electrophysiology of heart1.1 introduction of haemodynamics and electrophysiology of heart
1.1 introduction of haemodynamics and electrophysiology of heart
Arunachalam Muthuraman
 

What's hot (20)

Nitrates
NitratesNitrates
Nitrates
 
Antiarrhythmics
AntiarrhythmicsAntiarrhythmics
Antiarrhythmics
 
Cardiac Drugs
Cardiac DrugsCardiac Drugs
Cardiac Drugs
 
Heart- Physiology and Electrophysiology
Heart- Physiology and ElectrophysiologyHeart- Physiology and Electrophysiology
Heart- Physiology and Electrophysiology
 
Antiarrythmic drugs
Antiarrythmic drugsAntiarrythmic drugs
Antiarrythmic drugs
 
Class antiarrhythmic drugs
Class antiarrhythmic drugsClass antiarrhythmic drugs
Class antiarrhythmic drugs
 
arrhythmia management
arrhythmia management arrhythmia management
arrhythmia management
 
Antiarrhythmic drugs
Antiarrhythmic drugsAntiarrhythmic drugs
Antiarrhythmic drugs
 
Drugs acting on Renin Angiotensin Aldosterone system
Drugs acting on Renin Angiotensin Aldosterone system Drugs acting on Renin Angiotensin Aldosterone system
Drugs acting on Renin Angiotensin Aldosterone system
 
Antiarrhythmic agent
Antiarrhythmic agentAntiarrhythmic agent
Antiarrhythmic agent
 
Antiarrhythmic Drugs
Antiarrhythmic DrugsAntiarrhythmic Drugs
Antiarrhythmic Drugs
 
Cardiac electrophysiology
Cardiac electrophysiologyCardiac electrophysiology
Cardiac electrophysiology
 
14.antianginal drugs
14.antianginal drugs14.antianginal drugs
14.antianginal drugs
 
Arrhythmia & Antiarrhythmic Drugs
Arrhythmia & Antiarrhythmic DrugsArrhythmia & Antiarrhythmic Drugs
Arrhythmia & Antiarrhythmic Drugs
 
Antiarrhythmic drugs bds
Antiarrhythmic drugs bdsAntiarrhythmic drugs bds
Antiarrhythmic drugs bds
 
Pharmacology antiarrhythmias
Pharmacology   antiarrhythmiasPharmacology   antiarrhythmias
Pharmacology antiarrhythmias
 
Diuretics
DiureticsDiuretics
Diuretics
 
Antiarrhythmic agent.pptx
Antiarrhythmic agent.pptxAntiarrhythmic agent.pptx
Antiarrhythmic agent.pptx
 
Antiarrythmic drugs
Antiarrythmic drugs  Antiarrythmic drugs
Antiarrythmic drugs
 
1.1 introduction of haemodynamics and electrophysiology of heart
1.1 introduction of haemodynamics and electrophysiology of heart1.1 introduction of haemodynamics and electrophysiology of heart
1.1 introduction of haemodynamics and electrophysiology of heart
 

Viewers also liked

Dr fahad anti arrythmic drugs
Dr fahad anti arrythmic drugsDr fahad anti arrythmic drugs
Dr fahad anti arrythmic drugsMuhammad Saim
 
Anti arrhythmic drugs
Anti arrhythmic drugsAnti arrhythmic drugs
Anti arrhythmic drugs
kashyap36527
 
IVMS-CV Pharmacology- Antiarrhythmic Agents
IVMS-CV  Pharmacology- Antiarrhythmic AgentsIVMS-CV  Pharmacology- Antiarrhythmic Agents
IVMS-CV Pharmacology- Antiarrhythmic Agents
Imhotep Virtual Medical School
 
Antiarrhythmic drugs
Antiarrhythmic drugsAntiarrhythmic drugs
Antiarrhythmic drugs
Amr Elsharkawy
 
Antiarrhythmicdrug therapy Dr Vinay Verma
Antiarrhythmicdrug therapy       Dr Vinay Verma Antiarrhythmicdrug therapy       Dr Vinay Verma
Antiarrhythmicdrug therapy Dr Vinay Verma
Dr Harikrishna Harindran
 
MBBS antiarrhythmics 2012
MBBS antiarrhythmics 2012MBBS antiarrhythmics 2012
MBBS antiarrhythmics 2012Rathnakar U P
 
Basics of arrhythmias&antiarrhythmic drugs
Basics of arrhythmias&antiarrhythmic drugsBasics of arrhythmias&antiarrhythmic drugs
Basics of arrhythmias&antiarrhythmic drugs
Islam Ghanem
 
Evaluation of antiarrhythmicdrugs
Evaluation of antiarrhythmicdrugsEvaluation of antiarrhythmicdrugs
Evaluation of antiarrhythmicdrugs
shaffain
 
Antiarrhythmic drugs satya
Antiarrhythmic drugs satya Antiarrhythmic drugs satya
Antiarrhythmic drugs satya
sathyanarayanan varadarajan
 
Antiarrhythmic drugs p_light
Antiarrhythmic drugs p_lightAntiarrhythmic drugs p_light
Antiarrhythmic drugs p_light
Belal Shahab
 
Antiarrhythmic drugs. I.Ponnilavarasan, Professor,KMCH College of Pharmacy
Antiarrhythmic drugs. I.Ponnilavarasan, Professor,KMCH College of PharmacyAntiarrhythmic drugs. I.Ponnilavarasan, Professor,KMCH College of Pharmacy
Antiarrhythmic drugs. I.Ponnilavarasan, Professor,KMCH College of Pharmacy
Ilangovan Ponnilavarasan
 
Evaluation of antiarrhythmic drugs (1)
Evaluation of antiarrhythmic drugs (1)Evaluation of antiarrhythmic drugs (1)
Evaluation of antiarrhythmic drugs (1)
Nitin Shinde
 
Cardiotonic Drugs. Antiarrhythmic Agents
Cardiotonic Drugs. Antiarrhythmic AgentsCardiotonic Drugs. Antiarrhythmic Agents
Cardiotonic Drugs. Antiarrhythmic Agents
Ganapathy Tamilselvan
 
Antiarrhythmic drugs
Antiarrhythmic drugsAntiarrhythmic drugs
Antiarrhythmic drugs
Najaf-Farooq
 

Viewers also liked (20)

Dr fahad anti arrythmic drugs
Dr fahad anti arrythmic drugsDr fahad anti arrythmic drugs
Dr fahad anti arrythmic drugs
 
SVTagents
SVTagentsSVTagents
SVTagents
 
Anti arrhythmic drugs
Anti arrhythmic drugsAnti arrhythmic drugs
Anti arrhythmic drugs
 
Antiars
AntiarsAntiars
Antiars
 
Anti arrhythmic drugs
Anti arrhythmic drugsAnti arrhythmic drugs
Anti arrhythmic drugs
 
IVMS-CV Pharmacology- Antiarrhythmic Agents
IVMS-CV  Pharmacology- Antiarrhythmic AgentsIVMS-CV  Pharmacology- Antiarrhythmic Agents
IVMS-CV Pharmacology- Antiarrhythmic Agents
 
Antiarrhythmic drugs
Antiarrhythmic drugsAntiarrhythmic drugs
Antiarrhythmic drugs
 
Antiarrhythmicdrug therapy Dr Vinay Verma
Antiarrhythmicdrug therapy       Dr Vinay Verma Antiarrhythmicdrug therapy       Dr Vinay Verma
Antiarrhythmicdrug therapy Dr Vinay Verma
 
anti-arrhythmics
anti-arrhythmicsanti-arrhythmics
anti-arrhythmics
 
MBBS antiarrhythmics 2012
MBBS antiarrhythmics 2012MBBS antiarrhythmics 2012
MBBS antiarrhythmics 2012
 
Basics of arrhythmias&antiarrhythmic drugs
Basics of arrhythmias&antiarrhythmic drugsBasics of arrhythmias&antiarrhythmic drugs
Basics of arrhythmias&antiarrhythmic drugs
 
Evaluation of antiarrhythmicdrugs
Evaluation of antiarrhythmicdrugsEvaluation of antiarrhythmicdrugs
Evaluation of antiarrhythmicdrugs
 
Antiarrhythmic drugs satya
Antiarrhythmic drugs satya Antiarrhythmic drugs satya
Antiarrhythmic drugs satya
 
Antiarrhythmic drugs p_light
Antiarrhythmic drugs p_lightAntiarrhythmic drugs p_light
Antiarrhythmic drugs p_light
 
Antiarrhythmic drugs. I.Ponnilavarasan, Professor,KMCH College of Pharmacy
Antiarrhythmic drugs. I.Ponnilavarasan, Professor,KMCH College of PharmacyAntiarrhythmic drugs. I.Ponnilavarasan, Professor,KMCH College of Pharmacy
Antiarrhythmic drugs. I.Ponnilavarasan, Professor,KMCH College of Pharmacy
 
Pharm3-12-6-05
Pharm3-12-6-05Pharm3-12-6-05
Pharm3-12-6-05
 
Evaluation of antiarrhythmic drugs (1)
Evaluation of antiarrhythmic drugs (1)Evaluation of antiarrhythmic drugs (1)
Evaluation of antiarrhythmic drugs (1)
 
Cardiotonic Drugs. Antiarrhythmic Agents
Cardiotonic Drugs. Antiarrhythmic AgentsCardiotonic Drugs. Antiarrhythmic Agents
Cardiotonic Drugs. Antiarrhythmic Agents
 
Antiarrhythmic drugs
Antiarrhythmic drugsAntiarrhythmic drugs
Antiarrhythmic drugs
 
Antiarrhythmic drugs
Antiarrhythmic drugsAntiarrhythmic drugs
Antiarrhythmic drugs
 

Similar to Antiarrythmic drugs

ANTIARRHYTHMIC AGENTS IN VETERINARY PRACTICE.
ANTIARRHYTHMIC AGENTS IN VETERINARY PRACTICE.ANTIARRHYTHMIC AGENTS IN VETERINARY PRACTICE.
ANTIARRHYTHMIC AGENTS IN VETERINARY PRACTICE.
Dr. Sindhu K., Asst. Prof., Dept. of VPT, VCG.
 
Antiarrhythmic drugs class Bidya.pdf
Antiarrhythmic drugs class Bidya.pdfAntiarrhythmic drugs class Bidya.pdf
Antiarrhythmic drugs class Bidya.pdf
SaishDalvi
 
Anti arrhythmic drug thereapy
Anti arrhythmic drug thereapy Anti arrhythmic drug thereapy
Anti arrhythmic drug thereapy Dr. Pravin Wahane
 
Arrhythmias final
Arrhythmias finalArrhythmias final
Arrhythmias final
Wahid altaf Sheeba hakak
 
Arrhythmia
ArrhythmiaArrhythmia
Arrhythmia
Amira Badr
 
arrhythmia-211205224744.pdf33333333333333
arrhythmia-211205224744.pdf33333333333333arrhythmia-211205224744.pdf33333333333333
arrhythmia-211205224744.pdf33333333333333
DatDanid
 
Cardiac arrhythmias
Cardiac arrhythmiasCardiac arrhythmias
Cardiac arrhythmias
dratin75
 
Heart attacks & detection
Heart attacks & detectionHeart attacks & detection
Heart attacks & detectionAbhisek Anand
 
Preclinical Screening of Antiarrhythmatic Agents- Mpharm-edited.pptx
Preclinical Screening of Antiarrhythmatic Agents- Mpharm-edited.pptxPreclinical Screening of Antiarrhythmatic Agents- Mpharm-edited.pptx
Preclinical Screening of Antiarrhythmatic Agents- Mpharm-edited.pptx
Ashish Kumar Jha
 
Ekg powerpoint
Ekg powerpointEkg powerpoint
Ekg powerpoint
lsj0813
 
ANTIARRHYTHMIAS.ppt
ANTIARRHYTHMIAS.pptANTIARRHYTHMIAS.ppt
ANTIARRHYTHMIAS.ppt
mohammedturab2
 
arrhythbbbbbbbbbbbbbbbbbbbbbbbbmia .pptx
arrhythbbbbbbbbbbbbbbbbbbbbbbbbmia .pptxarrhythbbbbbbbbbbbbbbbbbbbbbbbbmia .pptx
arrhythbbbbbbbbbbbbbbbbbbbbbbbbmia .pptx
eman458700
 
arrhythnnnnnnnnnnnnnnnnnnnnmia post.pptx
arrhythnnnnnnnnnnnnnnnnnnnnmia post.pptxarrhythnnnnnnnnnnnnnnnnnnnnmia post.pptx
arrhythnnnnnnnnnnnnnnnnnnnnmia post.pptx
eman458700
 
Tachyarrhythmias
TachyarrhythmiasTachyarrhythmias
Tachyarrhythmias
Smita Jain
 
Management of cardiac arrhythmias
Management of cardiac arrhythmiasManagement of cardiac arrhythmias
Management of cardiac arrhythmias
Sameh Abdel-ghany
 
A heart physiology
A heart physiologyA heart physiology
A heart physiologylevouge777
 
Arrhytmias
ArrhytmiasArrhytmias
16 arrhythmias2009
16 arrhythmias200916 arrhythmias2009
16 arrhythmias2009internalmed
 
Cardiovascular pathology stomatological faculty
Cardiovascular pathology stomatological facultyCardiovascular pathology stomatological faculty
Cardiovascular pathology stomatological faculty
Ivano-Frankivsk National Medical University
 

Similar to Antiarrythmic drugs (20)

ANTIARRHYTHMIC AGENTS IN VETERINARY PRACTICE.
ANTIARRHYTHMIC AGENTS IN VETERINARY PRACTICE.ANTIARRHYTHMIC AGENTS IN VETERINARY PRACTICE.
ANTIARRHYTHMIC AGENTS IN VETERINARY PRACTICE.
 
Antiarrhythmic drugs class Bidya.pdf
Antiarrhythmic drugs class Bidya.pdfAntiarrhythmic drugs class Bidya.pdf
Antiarrhythmic drugs class Bidya.pdf
 
Anti arrhythmic drug thereapy
Anti arrhythmic drug thereapy Anti arrhythmic drug thereapy
Anti arrhythmic drug thereapy
 
Arrhythmias final
Arrhythmias finalArrhythmias final
Arrhythmias final
 
Arrhythmia
ArrhythmiaArrhythmia
Arrhythmia
 
arrhythmia-211205224744.pdf33333333333333
arrhythmia-211205224744.pdf33333333333333arrhythmia-211205224744.pdf33333333333333
arrhythmia-211205224744.pdf33333333333333
 
Cardiac arrhythmias
Cardiac arrhythmiasCardiac arrhythmias
Cardiac arrhythmias
 
Heart attacks & detection
Heart attacks & detectionHeart attacks & detection
Heart attacks & detection
 
Preclinical Screening of Antiarrhythmatic Agents- Mpharm-edited.pptx
Preclinical Screening of Antiarrhythmatic Agents- Mpharm-edited.pptxPreclinical Screening of Antiarrhythmatic Agents- Mpharm-edited.pptx
Preclinical Screening of Antiarrhythmatic Agents- Mpharm-edited.pptx
 
Ekg powerpoint
Ekg powerpointEkg powerpoint
Ekg powerpoint
 
ANTIARRHYTHMIAS.ppt
ANTIARRHYTHMIAS.pptANTIARRHYTHMIAS.ppt
ANTIARRHYTHMIAS.ppt
 
arrhythbbbbbbbbbbbbbbbbbbbbbbbbmia .pptx
arrhythbbbbbbbbbbbbbbbbbbbbbbbbmia .pptxarrhythbbbbbbbbbbbbbbbbbbbbbbbbmia .pptx
arrhythbbbbbbbbbbbbbbbbbbbbbbbbmia .pptx
 
arrhythnnnnnnnnnnnnnnnnnnnnmia post.pptx
arrhythnnnnnnnnnnnnnnnnnnnnmia post.pptxarrhythnnnnnnnnnnnnnnnnnnnnmia post.pptx
arrhythnnnnnnnnnnnnnnnnnnnnmia post.pptx
 
Tachyarrhythmias
TachyarrhythmiasTachyarrhythmias
Tachyarrhythmias
 
Arrhythmias
ArrhythmiasArrhythmias
Arrhythmias
 
Management of cardiac arrhythmias
Management of cardiac arrhythmiasManagement of cardiac arrhythmias
Management of cardiac arrhythmias
 
A heart physiology
A heart physiologyA heart physiology
A heart physiology
 
Arrhytmias
ArrhytmiasArrhytmias
Arrhytmias
 
16 arrhythmias2009
16 arrhythmias200916 arrhythmias2009
16 arrhythmias2009
 
Cardiovascular pathology stomatological faculty
Cardiovascular pathology stomatological facultyCardiovascular pathology stomatological faculty
Cardiovascular pathology stomatological faculty
 

Recently uploaded

Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
vimalpl1234
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Prof. Marcus Renato de Carvalho
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
LanceCatedral
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Dr Jeenal Mistry
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
SumeraAhmad5
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
NephroTube - Dr.Gawad
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Dr KHALID B.M
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
i3 Health
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
DrSathishMS1
 
New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
NEHA GUPTA
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
د.محمود نجيب
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
greendigital
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
Krishan Murari
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
Swetaba Besh
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
pal078100
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
KafrELShiekh University
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Savita Shen $i11
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
Anujkumaranit
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
MedicoseAcademics
 

Recently uploaded (20)

Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
 
New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
 

Antiarrythmic drugs

  • 1. Antiarrhythmic DrugsAntiarrhythmic Drugs OrOr Doing Drugs for Your HeartbeatDoing Drugs for Your Heartbeat
  • 2. BackgroundBackground Recall: to function efficiently, heart needs to contractRecall: to function efficiently, heart needs to contract sequentially (atria, then ventricles) and in synchronicitysequentially (atria, then ventricles) and in synchronicity Relaxation must occur between contractions (not true forRelaxation must occur between contractions (not true for other types of muscle [exhibit tetanyother types of muscle [exhibit tetany  contract and holdcontract and hold contraction for certain length of time])contraction for certain length of time]) Coordination of heartbeat is a result of a complex,Coordination of heartbeat is a result of a complex, coordinated sequence of changes in membranecoordinated sequence of changes in membrane potentials and electrical discharges in various heartpotentials and electrical discharges in various heart tissuestissues
  • 3. ArrhythmiaArrhythmia Heart condition where disturbances inHeart condition where disturbances in  Pacemaker impulse formationPacemaker impulse formation  Contraction impulse conductionContraction impulse conduction  Combination of the twoCombination of the two Results in rate and/or timing of contraction ofResults in rate and/or timing of contraction of heart muscle that is insufficient to maintainheart muscle that is insufficient to maintain normal cardiac output (CO)normal cardiac output (CO) To understand how antiarrhythmic drugs work,To understand how antiarrhythmic drugs work, need to understand electrophysiology ofneed to understand electrophysiology of normal contraction of heartnormal contraction of heart
  • 4. Normal heartbeat and atrial arrhythmiaNormal heartbeat and atrial arrhythmia Normal rhythm Atrial arrhythmia AV septum
  • 5. Ventricular ArrhythmiaVentricular Arrhythmia Ventricular arrhythmias areVentricular arrhythmias are common in most people and arecommon in most people and are usually not a problem but…usually not a problem but… VA’s are most common cause ofVA’s are most common cause of sudden deathsudden death Majority of sudden death occurs inMajority of sudden death occurs in people with neither a previouslypeople with neither a previously known heart disease nor history ofknown heart disease nor history of VA’sVA’s Medications which decreaseMedications which decrease incidence of VA’s do not decreaseincidence of VA’s do not decrease (and may increase) the risk of(and may increase) the risk of sudden deathsudden death treatment may betreatment may be worse then the disease!worse then the disease!
  • 6. Electrophysiology - resting potentialElectrophysiology - resting potential A transmembrane electrical gradient (potential) isA transmembrane electrical gradient (potential) is maintained, with the interior of the cell negative withmaintained, with the interior of the cell negative with respect to outside the cellrespect to outside the cell Caused by unequal distribution of ions inside vs. outsideCaused by unequal distribution of ions inside vs. outside cellcell  NaNa++ higher outside than inside cellhigher outside than inside cell  CaCa++ much higher “ “ “ “much higher “ “ “ “  KK++ higher inside cell than outsidehigher inside cell than outside Maintenance by ion selective channels, active pumpsMaintenance by ion selective channels, active pumps and exchangersand exchangers
  • 7. ECG (EKG) showing wave segments Contraction of atria Contraction of ventricles Repolarization of ventricles
  • 8. Cardiac Action PotentialCardiac Action Potential Divided into five phases (0,1,2,3,4)Divided into five phases (0,1,2,3,4)  Phase 4Phase 4 - resting phase (resting membrane potential)- resting phase (resting membrane potential) Phase cardiac cells remain in until stimulatedPhase cardiac cells remain in until stimulated Associated with diastole portion of heart cycleAssociated with diastole portion of heart cycle Addition of current into cardiac muscle (stimulation)Addition of current into cardiac muscle (stimulation) causescauses  Phase 0Phase 0 – opening of fast Na channels and rapid depolarization– opening of fast Na channels and rapid depolarization Drives NaDrives Na++ into cell (inward current), changing membrane potentialinto cell (inward current), changing membrane potential Transient outward current due to movement of ClTransient outward current due to movement of Cl-- and Kand K++  Phase 1Phase 1 – initial rapid repolarization– initial rapid repolarization Closure of the fast NaClosure of the fast Na++ channelschannels Phase 0 and 1 together correspond to the R and S waves of thePhase 0 and 1 together correspond to the R and S waves of the ECGECG
  • 10. Cardiac Action Potential (con’t)Cardiac Action Potential (con’t) Phase 2Phase 2 - plateau phase- plateau phase  sustained by the balance between the inward movement of Casustained by the balance between the inward movement of Ca++ andand outward movement of Koutward movement of K ++  Has a long duration compared to other nerve and muscle tissueHas a long duration compared to other nerve and muscle tissue  Normally blocks any premature stimulator signals (other muscle tissueNormally blocks any premature stimulator signals (other muscle tissue can accept additional stimulation and increase contractility in acan accept additional stimulation and increase contractility in a summation effect)summation effect)  Corresponds to ST segment of the ECG.Corresponds to ST segment of the ECG. Phase 3Phase 3 – repolarization– repolarization  KK++ channels remain open,channels remain open,  Allows KAllows K++ to build up outside the cell, causing the cell to repolarizeto build up outside the cell, causing the cell to repolarize  KK ++ channels finally close when membrane potential reaches certain levelchannels finally close when membrane potential reaches certain level  Corresponds to T wave on the ECGCorresponds to T wave on the ECG
  • 11. Differences between nonpacemaker andDifferences between nonpacemaker and pacemaker cell action potentialspacemaker cell action potentials PCs - Slow, continuous depolarization during restPCs - Slow, continuous depolarization during rest Continuously moves potential towards threshold for aContinuously moves potential towards threshold for a new action potential (called a phase 4 depolarization)new action potential (called a phase 4 depolarization)
  • 12. Mechanisms of Cardiac ArrhythmiasMechanisms of Cardiac Arrhythmias Result from disorders of impulseResult from disorders of impulse formation, conduction, or bothformation, conduction, or both Causes of arrhythmiasCauses of arrhythmias  Cardiac ischemiaCardiac ischemia  Excessive discharge or sensitivity toExcessive discharge or sensitivity to autonomic transmittersautonomic transmitters  Exposure to toxic substancesExposure to toxic substances  Unknown etiologyUnknown etiology
  • 13. Disorders of impulse formationDisorders of impulse formation No signal from the pacemaker siteNo signal from the pacemaker site Development of an ectopic pacemakerDevelopment of an ectopic pacemaker  May arise from conduction cells (most are capable ofMay arise from conduction cells (most are capable of spontaneous activity)spontaneous activity)  Usually under control of SA nodeUsually under control of SA node  if it slows down too muchif it slows down too much conduction cells could become dominantconduction cells could become dominant  Often a result of other injury (ischemia, hypoxia)Often a result of other injury (ischemia, hypoxia) Development of oscillatory afterdepolariztionsDevelopment of oscillatory afterdepolariztions  Can initiate spontaneous activity in nonpacemaker tissueCan initiate spontaneous activity in nonpacemaker tissue  May be result of drugs (digitalis, norepinephrine) used to treatMay be result of drugs (digitalis, norepinephrine) used to treat other cardiopathologiesother cardiopathologies
  • 15. Disorders of impulse conductionDisorders of impulse conduction May result inMay result in  Bradycardia (if have AV block)Bradycardia (if have AV block)  Tachycardia (if reentrant circuit occurs)Tachycardia (if reentrant circuit occurs) Reentrant circuit
  • 16. Antiarrhythmic drugsAntiarrhythmic drugs Biggest problem – antiarrhythmics canBiggest problem – antiarrhythmics can cause arrhythmia!cause arrhythmia!  Example: Treatment of a non-life threateningExample: Treatment of a non-life threatening tachycardia may cause fatal ventriculartachycardia may cause fatal ventricular arrhythmiaarrhythmia  Must be vigilant in determining dosing, bloodMust be vigilant in determining dosing, blood levels, and in follow-up when prescribinglevels, and in follow-up when prescribing antiarrhythmicsantiarrhythmics
  • 17. Therapeutic overviewTherapeutic overview NaNa++ channel blockadechannel blockade ββ-adrenergic receptor blockade-adrenergic receptor blockade Prolong repolarizationProlong repolarization CaCa2+2+ channel blockadechannel blockade AdenosineAdenosine Digitalis glycosidesDigitalis glycosides
  • 18. Classification of antiarrhythmicsClassification of antiarrhythmics (based on mechanisms of action)(based on mechanisms of action) Class I – blocker’s of fast NaClass I – blocker’s of fast Na++ channelschannels  Subclass IASubclass IA Cause moderate Phase 0 depressionCause moderate Phase 0 depression Prolong repolarizationProlong repolarization Increased duration of action potentialIncreased duration of action potential IncludesIncludes  QuinidineQuinidine – 1– 1stst antiarrhythmic used, treat both atrial andantiarrhythmic used, treat both atrial and ventricular arrhythmias, increases refractory periodventricular arrhythmias, increases refractory period  ProcainamideProcainamide - increases refractory period but side- increases refractory period but side effectseffects  DisopyramideDisopyramide – extended duration of action, used only– extended duration of action, used only for treating ventricular arrthymiasfor treating ventricular arrthymias
  • 19. Classification of antiarrhythmicsClassification of antiarrhythmics (based on mechanisms of action)(based on mechanisms of action)  Subclass IBSubclass IB Weak Phase 0 depressionWeak Phase 0 depression Shortened depolarizationShortened depolarization Decreased action potential durationDecreased action potential duration IncludesIncludes  LidocaneLidocane (also acts as local anesthetic) – blocks Na+(also acts as local anesthetic) – blocks Na+ channels mostly in ventricular cells, also good forchannels mostly in ventricular cells, also good for digitalis-associated arrhythmiasdigitalis-associated arrhythmias  MexiletineMexiletine - oral lidocaine derivative, similar activity- oral lidocaine derivative, similar activity  PhenytoinPhenytoin – anticonvulsant that also works as– anticonvulsant that also works as antiarrhythmic similar to lidocaneantiarrhythmic similar to lidocane
  • 20. Classification of antiarrhythmicsClassification of antiarrhythmics (based on mechanisms of action)(based on mechanisms of action)  Subclass ICSubclass IC Strong Phase 0 depressionStrong Phase 0 depression No effect of depolarizationNo effect of depolarization No effect on action potential durationNo effect on action potential duration IncludesIncludes  FlecainideFlecainide (initially developed as a local anesthetic)(initially developed as a local anesthetic) Slows conduction in all parts of heart,Slows conduction in all parts of heart, Also inhibits abnormal automaticityAlso inhibits abnormal automaticity  PropafenonePropafenone Also slows conductionAlso slows conduction WeakWeak ββ – blocker– blocker Also some CaAlso some Ca2+2+ channel blockadechannel blockade
  • 21. Classification of antiarrhythmicsClassification of antiarrhythmics (based on mechanisms of action)(based on mechanisms of action) Class II –Class II – ββ–adrenergic blockers–adrenergic blockers  Based on two major actionsBased on two major actions 1) blockade of myocardial1) blockade of myocardial ββ–adrenergic receptors–adrenergic receptors 2) Direct membrane-stabilizing effects related to Na2) Direct membrane-stabilizing effects related to Na++ channel blockadechannel blockade  IncludesIncludes PropranololPropranolol  causes both myocardialcauses both myocardial ββ–adrenergic blockade and membrane-–adrenergic blockade and membrane- stabilizing effectsstabilizing effects  Slows SA node and ectopic pacemakingSlows SA node and ectopic pacemaking  Can block arrhythmias induced by exercise or apprehensionCan block arrhythmias induced by exercise or apprehension  OtherOther ββ–adrenergic blockers have similar therapeutic effect–adrenergic blockers have similar therapeutic effect MetoprololMetoprolol NadololNadolol AtenololAtenolol AcebutololAcebutolol PindololPindolol StalolStalol TimololTimolol EsmololEsmolol
  • 22. Classification of antiarrhythmicsClassification of antiarrhythmics (based on mechanisms of action)(based on mechanisms of action) Class III – KClass III – K++ channel blockerschannel blockers  Developed because some patients negativelyDeveloped because some patients negatively sensitive to Na channel blockers (they died!)sensitive to Na channel blockers (they died!)  Cause delay in repolarization and prolongedCause delay in repolarization and prolonged refractory periodrefractory period  IncludesIncludes AmiodaroneAmiodarone – prolongs action potential by delaying K– prolongs action potential by delaying K++ effluxefflux but many other effects characteristic of other classesbut many other effects characteristic of other classes IbutilideIbutilide – slows inward movement of Na– slows inward movement of Na++ in addition toin addition to delaying Kdelaying K ++ influx.influx. BretyliumBretylium – first developed to treat hypertension but found to– first developed to treat hypertension but found to also suppress ventricular fibrillation associated withalso suppress ventricular fibrillation associated with myocardial infarctionmyocardial infarction Dofetilide - prolongs action potential by delaying KDofetilide - prolongs action potential by delaying K++ efflux withefflux with no other effectsno other effects
  • 23. Classification of antiarrhythmicsClassification of antiarrhythmics (based on mechanisms of action)(based on mechanisms of action) Class IV – CaClass IV – Ca2+2+ channel blockerschannel blockers  slow rate of AV-conduction in patients withslow rate of AV-conduction in patients with atrial fibrillationatrial fibrillation  IncludesIncludes Verapamil – blocks NaVerapamil – blocks Na++ channels in addition to Cachannels in addition to Ca2+;2+; also slows SA node in tachycardiaalso slows SA node in tachycardia DiltiazemDiltiazem
  • 24. PacemakersPacemakers Surgical implantation of electrical leads attached to aSurgical implantation of electrical leads attached to a pulse generatorpulse generator Over 175,000 implanted per yearOver 175,000 implanted per year 1)1) Leads are inserted via subclavicle vein and advanced to theLeads are inserted via subclavicle vein and advanced to the chambers on the vena cava (right) side of the heartchambers on the vena cava (right) side of the heart 2)2) Two leads used, one for right atrium, other for right ventricleTwo leads used, one for right atrium, other for right ventricle 3)3) Pulse generator containing microcircuitry and battery arePulse generator containing microcircuitry and battery are attached to leads and placed into a “pocket” under the skinattached to leads and placed into a “pocket” under the skin near the claviclenear the clavicle 4)4) Pulse generator sends signal down leads in programmedPulse generator sends signal down leads in programmed sequence to contract atria, then ventriclessequence to contract atria, then ventricles Pulse generator can sense electrical activity generatedPulse generator can sense electrical activity generated by the heart and only deliver electrical impulses whenby the heart and only deliver electrical impulses when needed.needed. Pacemakers can only speed up a heart experiencingPacemakers can only speed up a heart experiencing bradycardia, they cannot alter a condition ofbradycardia, they cannot alter a condition of tachycardiatachycardia